Joel Maamary
Research Subjects
Joel Maamary has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
Benjamin Jonker
School of Medical Sciences, The University of New South Wales
5 shared publicationsYael Barnett
School of Medical Sciences, The University of New South Wales
5 shared publicationsJames Peters
Department of Neurology, St Vincent’s Health Network
3 shared publicationsKain Kyle
The University of Sydney
3 shared publicationsStephen Tisch
Department of Neurology, St Vincent’s Health Network
3 shared publications- James Peters
Department of Neurology St Vincent's Health Network Sydney New South Wales Australia
2 shared publications
Latest Publications
- Open Access
- 2 November 2026
- Published by Frontiers Media SA in Frontiers in Radiology
- Vol. 6, 1942583
Structural and functional network changes following thalamotomy for focal dystonia: a multimodal MRI study
Converging evidence supports dystonia as a disorder of large-scale brain networks arising from dysfunction within, or impaired communication between, nodes of the cortico-basal ganglia-thalamo-cortical and cerebello-thalamo-cortical circuits. Focal hand dystonia is associated with abnormalities across cortical and subcortical networks. High intensity focused ultrasound (HiFU) offers a novel therapeutic approach that provides an opportunity to examine treatment related structural and functional network changes. Eleven individuals with focal hand dystonia, of musician's dystonia and writer's cramp subtype, underwent multimodal MRI, including structural analysis, diffusion tensor imaging (DTI), and resting-state functional MRI (rs-fMRI) at baseline, with comparison made to ten age- and sex-matched healthy control participants. These imaging metrics were repeated at 1, 3 and 12 months following HiFU ventro-oral (Vo)-complex thalamotomy. This trial was registered with the Australia New Zealand Clinical Trials Registry (ACTRN12622000775718p). No differences in regional volumes were observed at baseline between the groups. Following thalamotomy, small uncorrected volumetric changes were noted in several regions of interest, and DTI demonstrated lower tract-wise fractional anisotropy (FA) and coefficient of linearity (CL) within the treated pallidothalamic tract, with node-wise analysis demonstrating focal microstructural alterations that were most apparent at 12 months following treatment. There were no corresponding changes in fronto-striatal or fronto-thalamic tracts. rs-fMRI revealed baseline alterations in intra- and inter-network connectivity involving sensorimotor, visual, attentional, default mode and executive networks. Following thalamotomy, changes in functional connectivity were modest and temporally variable, without evidence of large-scale network reorganisation. These findings suggest that focal hand dystonia is associated with distributed functional network dysfunction, in the context of preserved macroscopic structure. We propose that Vo-complex thalamotomy is associated with focal, localized microstructural alterations within the pallidothalamic tract, most notable at 12 months, which may contribute to modulation of pathological pallidothalamic drive rather than widespread restoration of functional network connectivity.
- 2 November 2026
- Published by Frontiers Media SA in Frontiers in Radiology
- Vol. 6, 1942583
Open AccessStructural and functional network changes following thalamotomy for focal dystonia: a multimodal MRI study
Converging evidence supports dystonia as a disorder of large-scale brain networks arising from dysfunction within, or impaired communication between, nodes of the cortico-basal ganglia-thalamo-cortical and cerebello-thalamo-cortical circuits. Focal hand dystonia is associated with abnormalities across cortical and subcortical networks. High intensity focused ultrasound (HiFU) offers a novel therapeutic approach that provides an opportunity to examine treatment related structural and functional network changes. Eleven individuals with focal hand dystonia, of musician's dystonia and writer's cramp subtype, underwent multimodal MRI, including structural analysis, diffusion tensor imaging (DTI), and resting-state functional MRI (rs-fMRI) at baseline, with comparison made to ten age- and sex-matched healthy control participants. These imaging metrics were repeated at 1, 3 and 12 months following HiFU ventro-oral (Vo)-complex thalamotomy. This trial was registered with the Australia New Zealand Clinical Trials Registry (ACTRN12622000775718p). No differences in regional volumes were observed at baseline between the groups. Following thalamotomy, small uncorrected volumetric changes were noted in several regions of interest, and DTI demonstrated lower tract-wise fractional anisotropy (FA) and coefficient of linearity (CL) within the treated pallidothalamic tract, with node-wise analysis demonstrating focal microstructural alterations that were most apparent at 12 months following treatment. There were no corresponding changes in fronto-striatal or fronto-thalamic tracts. rs-fMRI revealed baseline alterations in intra- and inter-network connectivity involving sensorimotor, visual, attentional, default mode and executive networks. Following thalamotomy, changes in functional connectivity were modest and temporally variable, without evidence of large-scale network reorganisation. These findings suggest that focal hand dystonia is associated with distributed functional network dysfunction, in the context of preserved macroscopic structure. We propose that Vo-complex thalamotomy is associated with focal, localized microstructural alterations within the pallidothalamic tract, most notable at 12 months, which may contribute to modulation of pathological pallidothalamic drive rather than widespread restoration of functional network connectivity.
- 25 April 2024
- Published by Wiley in Movement Disorders
- Vol. 39 (4) , 759-760
Reply to: Recurrence of Parkinson's Disease Tremor after Focused Ultrasound Thalamotomy?
- 25 April 2024
- Published by Wiley in Movement Disorders
- Vol. 39 (4) , 759-760
Reply to: Recurrence of Parkinson's Disease Tremor after Focused Ultrasound Thalamotomy?
- Open Access
- 14 November 2023
- Published by Wiley in Movement Disorders
- Vol. 39 (1) , 173-182
Outcomes of Focused Ultrasound Thalamotomy in Tremor Syndromes
Background: The current literature comparing outcomes after a unilateral magnetic resonance image–guided focused ultrasound (MRgFUS) thalamotomy between tremor syndromes is limited and remains a possible preoperative factor that could help predict the long‐term outcomes.Objective: The aim was to report on the outcomes between different tremor syndromes after a unilateral MRgFUS thalamotomy.Methods: A total of 66 patients underwent a unilateral MRgFUS thalamotomy for tremor between November 2018 and May 2020 at St Vincent's Hospital Sydney. Each patient's tremor syndrome was classified prior to treatment. Clinical assessments, including the hand tremor score (HTS) and Quality of Life in Essential Tremor Questionnaire (QUEST), were performed at baseline and predefined intervals to 36 months.Results: A total of 63 patients, comprising 30 essential tremor (ET), 24 dystonic tremor (DT), and 9 Parkinson's disease tremor (PDT) patients, returned for at least one follow‐up. In the ET patients, at 24 months there was a 61% improvement in HTS and 50% improvement in QUEST compared to baseline. This is in comparison to PDT patients, where an initial benefit in HTS and QUEST was observed, which waned at each follow‐up, remaining significant only up until 12 months. In the DT patients, similar results were observed to the ET patients: at 24 months there was a 61% improvement in HTS and 43% improvement in QUEST compared to baseline.Conclusion: These results support the use of unilateral MRgFUS thalamotomy for the treatment of DT, which appears to have a similar expected outcome to patients diagnosed with ET. Patients with PDT should be warned that there is a risk of treatment failure. © 2023 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
- 14 November 2023
- Published by Wiley in Movement Disorders
- Vol. 39 (1) , 173-182
Open AccessOutcomes of Focused Ultrasound Thalamotomy in Tremor Syndromes
Background: The current literature comparing outcomes after a unilateral magnetic resonance image–guided focused ultrasound (MRgFUS) thalamotomy between tremor syndromes is limited and remains a possible preoperative factor that could help predict the long‐term outcomes.Objective: The aim was to report on the outcomes between different tremor syndromes after a unilateral MRgFUS thalamotomy.Methods: A total of 66 patients underwent a unilateral MRgFUS thalamotomy for tremor between November 2018 and May 2020 at St Vincent's Hospital Sydney. Each patient's tremor syndrome was classified prior to treatment. Clinical assessments, including the hand tremor score (HTS) and Quality of Life in Essential Tremor Questionnaire (QUEST), were performed at baseline and predefined intervals to 36 months.Results: A total of 63 patients, comprising 30 essential tremor (ET), 24 dystonic tremor (DT), and 9 Parkinson's disease tremor (PDT) patients, returned for at least one follow‐up. In the ET patients, at 24 months there was a 61% improvement in HTS and 50% improvement in QUEST compared to baseline. This is in comparison to PDT patients, where an initial benefit in HTS and QUEST was observed, which waned at each follow‐up, remaining significant only up until 12 months. In the DT patients, similar results were observed to the ET patients: at 24 months there was a 61% improvement in HTS and 43% improvement in QUEST compared to baseline.Conclusion: These results support the use of unilateral MRgFUS thalamotomy for the treatment of DT, which appears to have a similar expected outcome to patients diagnosed with ET. Patients with PDT should be warned that there is a risk of treatment failure. © 2023 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
- Open Access
- 24 October 2023
- Published by BMJ in BMJ Neurology Open
- Vol. 5 (2) , e000522
Evaluation of the efficacy and safety of MRI-guided focused ultrasound (MRgFUS) for focal hand dystonia: study protocol for an open-label non-randomised clinical trial
Introduction MRI-guided focused ultrasound (MRgFUS) thalamotomy provides an exciting development in the field of minimally invasive stereotactic neurosurgery. Current treatment options for focal hand dystonia are limited, with potentially more effective invasive stereotactic interventions, such as deep brain stimulation or lesional therapies, rarely used. The advent of minimally invasive brain lesioning provides a potentially safe and effective treatment approach with a recent pilot study establishing MRgFUS Vo-complex thalamotomy as an effective treatment option for focal hand dystonia. In this study, we undertake an open-label clinical trial to further establish MRgFUS Vo-complex thalamotomy as an effective treatment for focal hand dystonia with greater attention paid to potential motor costs associated with this treatment. To elucidate pathophysiology of dystonia and treatment mechanisms, neurophysiological and MRI analysis will be performed longitudinally to explore the hypothesis that neuroplastic and structural changes that may underlie this treatment benefit. Methods and analysis A total of 10 participants will be recruited into this open-label clinical trial. All participants will undergo clinical, kinemetric, neurophysiological and radiological testing at baseline, followed by repeated measures at predesignated time points post MRgFUS Vo-complex thalamotomy. Further, to identify any underlying structural or neurophysiological abnormalities present in individuals with focal hand dystonia, 10 age and gender matched control participants will be recruited to undergo comparative investigation. These results will be compared with the intervention participants both at baseline and at 12 months to assess for normalisation of these abnormalities, if present. Ethics and dissemination This trial was reviewed and approved by the St Vincent’s Health Network Sydney Human Research Ethics Committee (2022/ETH00778). Study results will be published in peer-reviewed journals and presented at both national and international conferences. Trial registration number CTRN12622000775718.
- 24 October 2023
- Published by BMJ in BMJ Neurology Open
- Vol. 5 (2) , e000522
Open AccessEvaluation of the efficacy and safety of MRI-guided focused ultrasound (MRgFUS) for focal hand dystonia: study protocol for an open-label non-randomised clinical trial
Introduction MRI-guided focused ultrasound (MRgFUS) thalamotomy provides an exciting development in the field of minimally invasive stereotactic neurosurgery. Current treatment options for focal hand dystonia are limited, with potentially more effective invasive stereotactic interventions, such as deep brain stimulation or lesional therapies, rarely used. The advent of minimally invasive brain lesioning provides a potentially safe and effective treatment approach with a recent pilot study establishing MRgFUS Vo-complex thalamotomy as an effective treatment option for focal hand dystonia. In this study, we undertake an open-label clinical trial to further establish MRgFUS Vo-complex thalamotomy as an effective treatment for focal hand dystonia with greater attention paid to potential motor costs associated with this treatment. To elucidate pathophysiology of dystonia and treatment mechanisms, neurophysiological and MRI analysis will be performed longitudinally to explore the hypothesis that neuroplastic and structural changes that may underlie this treatment benefit. Methods and analysis A total of 10 participants will be recruited into this open-label clinical trial. All participants will undergo clinical, kinemetric, neurophysiological and radiological testing at baseline, followed by repeated measures at predesignated time points post MRgFUS Vo-complex thalamotomy. Further, to identify any underlying structural or neurophysiological abnormalities present in individuals with focal hand dystonia, 10 age and gender matched control participants will be recruited to undergo comparative investigation. These results will be compared with the intervention participants both at baseline and at 12 months to assess for normalisation of these abnormalities, if present. Ethics and dissemination This trial was reviewed and approved by the St Vincent’s Health Network Sydney Human Research Ethics Committee (2022/ETH00778). Study results will be published in peer-reviewed journals and presented at both national and international conferences. Trial registration number CTRN12622000775718.
- 30 January 2023
- Published by Wiley in Movement Disorders Clinical Practice
- Vol. 10 (3) , 486-492
Effective Subthalamic Nucleus Deep Brain Stimulation Following MRgFUS for Tremor Dominant Parkinson's Disease
Background: Whilst MRI guided Focused Ultrasound (MRgFUS) thalamotomy is an effective treatment option for tremor disorders, there are reports of tremor recurrence in patients with tremor dominant Parkinson's disease (PD). The mechanisms for tremor recurrence are unknown but likely relate to the duality of tremor network pathways with ramifications for subsequent treatment options.Cases: We report two cases of tremor dominant PD who experienced tremor recurrence following MRgFUS thalamotomy with subsequent successful subthalamic nucleus deep brain stimulation (DBS). Tremor scores were measured at baseline, 1‐ and 3‐months post MRgFUS and at least 18 months post DBS in both patients. Both cases evidenced immediate improvement in tremor, after MRgFUS, followed by subsequent tremor recurrence. STN DBS resulted in almost complete long‐term tremor alleviation in both cases.Conclusions: These cases demonstrate the efficacy and feasibility of STN DBS in patients with tremor dominant PD with tremor recurrence following MRgFUS thalamotomy. We discuss the dualism of tremor outflow pathways that may have implications for single target lesional therapies.
- 30 January 2023
- Published by Wiley in Movement Disorders Clinical Practice
- Vol. 10 (3) , 486-492
Effective Subthalamic Nucleus Deep Brain Stimulation Following MRgFUS for Tremor Dominant Parkinson's Disease
Background: Whilst MRI guided Focused Ultrasound (MRgFUS) thalamotomy is an effective treatment option for tremor disorders, there are reports of tremor recurrence in patients with tremor dominant Parkinson's disease (PD). The mechanisms for tremor recurrence are unknown but likely relate to the duality of tremor network pathways with ramifications for subsequent treatment options.Cases: We report two cases of tremor dominant PD who experienced tremor recurrence following MRgFUS thalamotomy with subsequent successful subthalamic nucleus deep brain stimulation (DBS). Tremor scores were measured at baseline, 1‐ and 3‐months post MRgFUS and at least 18 months post DBS in both patients. Both cases evidenced immediate improvement in tremor, after MRgFUS, followed by subsequent tremor recurrence. STN DBS resulted in almost complete long‐term tremor alleviation in both cases.Conclusions: These cases demonstrate the efficacy and feasibility of STN DBS in patients with tremor dominant PD with tremor recurrence following MRgFUS thalamotomy. We discuss the dualism of tremor outflow pathways that may have implications for single target lesional therapies.